局部晚期直肠癌多模式治疗后的决策后悔
这项双中心横断面观察研究纳入157例局部晚期直肠癌(UICC II/III)患者,采用决策后悔量表评估多模式治疗后的决策后悔。70.7%的患者报告决策后悔,31.8%存在严重决策后悔;决策后悔与较差生活质量和较低决策参与度独立相关,而与治疗方式无关。
要点
- 70.7%的患者放疗后报告决策后悔,31.8%为严重决策后悔。
- 决策后悔与较差生活质量、较低决策参与度独立相关。
- 保器官治疗与三模式治疗的决策后悔无显著差异。
核心结论
- 决策后悔在局部晚期直肠癌多模式治疗后患者中占相当比例,具有临床相关性。
- 决策后悔与更差的生活质量和更低的决策参与度独立相关。
研究设计与样本
- 双中心横断面观察研究,纳入157例局部晚期直肠癌(UICC II/III)患者。
- 使用5条目决策后悔量表测量决策后悔,并采用经验证问卷评估生活质量、进展恐惧、复发恐惧、抑郁焦虑、社会支持和决策参与度。
主要发现
- 患者平均年龄68.8±9.4岁,67%为男性;放疗至调查完成平均间隔35.1±19.8个月。
- 76.6%接受手术切除,23.4%接受保器官治疗。
- 111例(70.7%)报告放疗后决策后悔,其中50例(31.8%)为严重决策后悔(>25分)。
- 决策后悔与进展恐惧(r=0.26,p<0.001)、复发恐惧(r=0.29,p<0.001)和心理痛苦(r=0.28,p<0.001)正相关。
- 决策后悔与决策参与度(r=-0.23,p=0.004)和生活质量(r=-0.40,p<0.001)负相关。
关键数值与推荐
- 决策后悔在保器官治疗与三模式治疗之间无显著差异(p=0.095)。
- 决策后悔在不同治疗方式之间无显著差异(p=0.821)。
- 多变量回归分析显示较低总体生活质量(p=0.026)和较低决策参与度(p=0.019)与决策后悔独立相关。
临床怎么用
- 对局部晚期直肠癌多模式治疗患者应关注决策后悔,尤其生活质量较差或决策参与度较低者。
- 临床决策中应加强患者参与决策以可能降低决策后悔。
局限性
- 横断面设计无法确定因果关系。
- 作者指出未来需在更大规模纵向队列中研究决策后悔的预测因素并评估减少决策后悔的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study examines decision regret (DR) in patients with locally advanced rectal cancer (UICC II/III) after multimodal treatment. We assessed prevalence, risk factors, and the impact of treatment schedules on DR. METHODS: In this bicenter cross-sectional observational study, DR was measured using the 5-item Decision Regret Scale. Additional validated questionnaires assessed quality of life (QoL), fear of progression (FoP) and recurrence (FoR), depression and anxiety, social support, and perceived participation in decision-making (PDM). Parametric tests and linear regression were used for group comparisons and predictor analysis. RESULTS: 157 patients were included in the final analysis (mean age 68.8 ± 9.4 years; 67% male). The mean interval between radiotherapy (RT) and survey completion was 35.1 ± 19.8 months; 76.6% underwent surgical resection and 23.4% organ-preserving treatment. DR following RT was reported from 111 patients (70.7%), with 50 patients (31.8%) showing severe DR (>25 points). DR was correlated with FoP (r = 0.26, p < 0.001), FoR (r = 0.29, p < 0.001), and psychological distress (r = 0.28, p < 0.001). Conversely, DR was negatively correlated with PDM (r = - 0.23, p = 0.004) and QoL (r = - 0.40, p < 0.001). DR did not differ significantly between organ-preserving and trimodal treatment (p = 0.095) or between treatment modalities (p = 0.821). Multivariable regression analysis revealed lower global QoL (p = 0.026) and PDM (p = 0.019) to be independently associated with DR. CONCLUSIONS: DR was observed in a considerable proportion of patients in our cohort, underscoring its clinical relevance. DR was independently associated with worse QoL and lower PDM. Future studies should examine predictors of DR in larger, longitudinal cohorts and assess interventions to reduce DR.
引用
- Werfel T, Rühle A, Seidel C, et al. Decision regret in patients with rectal cancer undergoing multimodal therapy. Clin Transl Radiat Oncol. 2026. PMID: 42281958. doi:10.1016/j.ctro.2026.101211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。